Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
dpa

HOME > dpa

German chemical company BASF expects to post 2022 loss

January 19, 2023


Abstract : German chemical giant BASF said that it expects to report a loss for the fiscal year, compared to last year's profit.

CAPTION: German chemical company BASF expects to post 2022 loss. (picture alliance/dpa/Uwe Anspach)

German chemical giant BASF said that it expects to report a loss for the fiscal year, compared to last year's profit.

The loss is expected due to non-cash-effective impairments on the shareholding in the gas and oil company Wintershall Dea, the company said.

Annual preliminary operating profit, or EBIT, before special items are at the level of average analyst estimates. But EBIT, a key earnings metric, is below analyst consensus due to non-cash-effective impairment.

BASF Group expects net loss to be €1.38 billion ($1.49 billion) in 2022, compared to net income of €5.52 billion in 2021.

It is considerably below the average analyst estimates of €4.77 billion.

The 2022 result included non-cash-effective impairments on the shareholding in Wintershall Dea in the amount of about €7.3 billion.

These impairments result in particular from the deconsolidation of the Russian exploration and production activities of Wintershall Dea due to the extensive loss of actual influence and economic expropriation.

Wintershall Dea intends to fully exit Russia in an orderly manner complying with all applicable legal obligations.

Sales for 2022 rose by 11% to €87.33 billion from the prior year and were thus in line with the €86 billion to €89 billion range forecast by BASF.

The average analyst estimates for sales 2022 of the BASF Group were €87.95 billion according to Vara.

The increase in sales was mainly driven by higher prices and positive currency effects.

Annual EBIT before special items amounted to €6.88 billion, a decrease of €890 million from the prior year.

The BASF Group's EBIT amounted to €6.55 billion in 2022, below the figure for the prior year of €7.68 billion.

Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.

Scan the QR code and push it to your mobile phone

Keyword: BASF

Reading:

German business leaders optimistic about future cooperation with China

Sino-German cooperation benefits all with win-win prospects

German chemical company BASF earns significantly less in Q3

Foreign investors stay confident in Chinese market

China Focus: Strong appeal to foreign companies sustained by unwavering opening-up

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial